These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27045030)

  • 21. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
    Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
    Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitin specific protease 38 aggravates pathological cardiac remodeling by stabilizing phospho-TBK1.
    Xiao Z; Dai C; Yu T; Zhu J; Pan Y; Shuai W; Kong B; Huang H
    Int J Biol Sci; 2024; 20(5):1815-1832. PubMed ID: 38481817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.
    Liu X; Yang Q; Zhu LH; Liu J; Deng KQ; Zhu XY; Liu Y; Gong J; Zhang P; Li S; Xia H; She ZG
    J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29945911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual specific phosphatase 12 ameliorates cardiac hypertrophy in response to pressure overload.
    Li WM; Zhao YF; Zhu GF; Peng WH; Zhu MY; Yu XJ; Chen W; Xu DC; Xu YW
    Clin Sci (Lond); 2017 Jan; 131(2):141-154. PubMed ID: 27702885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice.
    Ma ZG; Yuan YP; Zhang X; Xu SC; Kong CY; Song P; Li N; Tang QZ
    Cardiovasc Res; 2019 May; 115(6):1067-1077. PubMed ID: 30407523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.
    Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C
    Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
    Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
    Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling.
    Pillai VB; Sundaresan NR; Kim G; Samant S; Moreno-Vinasco L; Garcia JG; Gupta MP
    Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H415-26. PubMed ID: 23203961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling.
    Ji YX; Zhang P; Zhang XJ; Zhao YC; Deng KQ; Jiang X; Wang PX; Huang Z; Li H
    Nat Commun; 2016 Jun; 7():11267. PubMed ID: 27249171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL3-mediated m6A modification of OTUD1 aggravates press overload induced myocardial hypertrophy by deubiquitinating PGAM5.
    Huang K; Sun X; Xu X; Lu J; Zhang B; Li Q; Wang C; Ding S; Huang X; Liu X; Xu Z; Han L
    Int J Biol Sci; 2024; 20(12):4908-4921. PubMed ID: 39309432
    [No Abstract]   [Full Text] [Related]  

  • 31. Critical Role of ADAMTS2 (A Disintegrin and Metalloproteinase With Thrombospondin Motifs 2) in Cardiac Hypertrophy Induced by Pressure Overload.
    Wang X; Chen W; Zhang J; Khan A; Li L; Huang F; Qiu Z; Wang L; Chen X
    Hypertension; 2017 Jun; 69(6):1060-1069. PubMed ID: 28373586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
    Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
    Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
    Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
    J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway.
    Hui X; Hu F; Liu J; Li C; Yang Y; Shu S; Liu P; Wang F; Li S
    J Mol Cell Cardiol; 2021 Feb; 151():31-43. PubMed ID: 32971071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
    Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
    Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different roles of BAG3 in cardiac physiological hypertrophy and pathological remodeling.
    Jia P; Wu N; Yang H; Guo Y; Guo X; Sun Y
    Transl Res; 2021 Jul; 233():47-61. PubMed ID: 33578031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNF207 exacerbates pathological cardiac hypertrophy via post-translational modification of TAB1.
    Yuan L; Bu S; Du M; Wang Y; Ju C; Huang D; Xu W; Tan X; Liang M; Deng S; Yang L; Huang K
    Cardiovasc Res; 2023 Mar; 119(1):183-194. PubMed ID: 35352799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth Arrest-Specific 6 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy.
    Zhao YF; Xu DC; Zhu GF; Zhu MY; Tang K; Li WM; Xu YW
    Hypertension; 2016 Jan; 67(1):118-29. PubMed ID: 26573712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
    Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
    Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
    Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
    Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.